検索
Teva Pharmaceutical Industries Ltd
TEVAウォッチリストに追加
35.000USD
-0.410-1.16%
終値 07-31 16:00（ET）15分遅れの株価
40.77B時価総額
28.42直近12ヶ月PER
詳細情報 Teva Pharmaceutical Industries Ltd 企業名
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltdの企業情報
企業コードTEVA
会社名Teva Pharmaceutical Industries Ltd
上場日Feb 06, 2087
最高経営責任者「CEO」Francis (Richard D)
従業員数33892
証券種類Depository Receipt
決算期末Feb 06
本社所在地124 Dvora Hanevi'a St.
都市TEL AVIV-YAFO
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国Israel
郵便番号6944020
電話番号97239148213
ウェブサイトhttps://www.tevapharm.com/
企業コードTEVA
上場日Feb 06, 2087
最高経営責任者「CEO」Francis (Richard D)
Teva Pharmaceutical Industries Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
14.49K
--
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
よくある質問
Teva Pharmaceutical Industries Ltdの上位5名の株主は誰ですか？
Teva Pharmaceutical Industries Ltdの上位5名の株主は以下のとおりです。Prof. Varda Shalev
Teva Pharmaceutical Industries Ltd（TEVA）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Teva Pharmaceutical Industries Ltdの株式を保有している機関は1226社あり、保有株式の総市場価値は約725.07Mで、全体の62.27%を占めています。2025Q4と比較して、機関の持ち株は9191465.00増加しています。
Teva Pharmaceutical Industries Ltdの最大の収益源は何ですか？
2026Q1において、Generic products部門がTeva Pharmaceutical Industries Ltdにとって最大の収益を生み出しており、その金額は9.42Bで、全収益の54.59%を占めています。